EPO906 Therapy in Patients With Advanced Breast Cancer
NCT00035126
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Neoplasms
Interventions
DRUG:
epothilone b
Sponsor
Novartis Pharmaceuticals